Agenus Inc (AGEN)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

3 FORBES ROAD LEXINGTON, MA 02421

Operates as a biotechnology firm, and develops products to treat cancers, infectious diseases and autoimmune disorders. Produces some of its lead product candidates in its own manufacturing and research and development facility and contracts out other candidates.

Data based on most recent fiscal year report
Market Cap535.704 Million Shares Outstanding137.36 Million Avg Volume1.573 Million
1-Yr BETA vs S&P TR0.886 Current Ratio1.1 Quick Ratio1.1
View SEC Filings from AGEN instead.

View recent insider trading info

Funds Holding AGEN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AGEN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WENTWORTH KERRY CHIEF REGULATORY OFFICER

  • Officer
87,061 2020-03-02 0

SHARP SHALINI CFO & EXECUTIVE VICE PRESIDENT

  • Officer
103,832 2020-03-01 0

ARMEN GARO H EXECUTIVE CHAIRMAN

  • Officer
  • Director
  • 10% Owner
0 2020-02-21 5

CORVESE BRIAN

  • Director
0 2020-02-21 2

STEIN ROBERT BENJAMIN

  • Director
0 2020-02-21 0

VALENTINE KAREN CHIEF LEGAL OFFICER

  • Officer
0 2020-02-14 0

MALIK SHAHZAD

  • Director
0 2020-01-21 0

JORDAN WADIH

  • Director
0 2020-01-02 5

WRIGHT TIMOTHY

  • Director
0 2020-01-02 5

WIINBERG ULF

  • Director
0 2020-01-02 5

INCYTE CORP

  • 10% Owner
3,200,000 2019-12-31 0

KLASKIN CHRISTINE M PFO AND PAO

  • Officer
0 2019-12-24 4

BUELL JENNIFER CHIEF OPERATING OFFICER

  • Officer
0 2019-12-24 3

KEARNS EVAN SEE REMARKS

  • Officer
0 2019-12-24 3

JEYNES-ELLIS ALLISON M

  • Director
0 2019-12-24 2

THORNTON PETER J.

  • Director
33,055 2019-08-07 0

DUNCAN ALEX CHIEF TECHNOLOGY OFFICER

  • Officer
0 2019-07-23 2

CORTIS CHRISTIAN CHIEF STRATEGY OFFICER

  • Officer
0 2019-07-23 2

QVT ASSOCIATES GP LLC

QVT FUND V LP

  • Director
  • 10% Owner
  • SEE REMARKSSEE REMARKS
0 2019-07-10 0

LEVITSKY HYAM

  • Director
0 2019-04-01 0

BAYSAL OZER CHIEF COMMERCIAL OFFICER

  • Officer
0 2018-06-20 0

HATSOPOULOS JOHN CO-CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2017-05-23 0

ROTHWELL TIMOTHY G

  • Director
0 2017-05-18 0

CUILLEROT JEAN-MARIE CHIEF MEDICAL OFFICER

  • Officer
0 2017-03-31 0

BALLANTYNE CHARLES EVAN CFO

  • Officer
0 2016-06-14 0

DECHAENE TOM

  • Director
No longer subject to file 2016-01-04 0

MARGARET EISEN

  • Director
No longer subject to file 2009-06-11 0

INVUS PUBLIC EQUITIES ADVISORS, LLC

INVUS PUBLIC EQUITIES, LP

ULYS, LLC

DEBBANE RAYMOND

  • 10% Owner
No longer subject to file 2009-04-24 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments